## LVS: Las Vegas Sands Corp. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -2.2% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($63.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. iSAM Funds UK Ltd Buys Shares of 21,686 Las Vegas Sands Corp. $LVS**
- Source: MarketBeat | 20251210T120957 | Somewhat-Bullish | Relevance: 100%
-  iSAM Funds UK Ltd has acquired 21,686 shares of Las Vegas Sands Corp. (NYSE:LVS) recently, valued at approximately $944,000. This comes as other institutional investors have also increased their holdings, contributing to a "Moderate Buy" consensus among analysts with an average price target of $65.80. The company recently beat earnings estimates and raised its quarterly dividend, though insiders have sold a significant number of shares.

**2. Las Vegas Sands Stock: Is LVS Outperforming the Consumer Discretionary Sector?**
- Source: Yahoo Finance | 20251209T110818 | Bullish | Relevance: 99%
-  Las Vegas Sands Corp. (LVS) has significantly outperformed the Consumer Discretionary sector, as evidenced by its 24.8% gain over the past three months compared to the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) which marginally declined. This outperformance extends to longer terms, with LVS up 24.3% over the past 52 weeks and 66.8% over the past six months, driven by strong Q3 2025 results that beat analysts' expectations. Wall Street analysts are moderately bullish on LVS, giving it a "Moderate Buy" consensus rating.

**3. LVS: UBS Maintains Neutral Rating, Raises Target Price to $68 | LVS Stock News**
- Source: GuruFocus | 20251208T153914 | Somewhat-Bullish | Relevance: 99%
-  UBS has maintained a Neutral rating on Las Vegas Sands (LVS) while increasing its target price from $67 to $68. This adjustment reflects a 1.49% rise in the target price, with the firm anticipating neutral growth prospects for the stock. Other analysts have also recently updated their ratings and price targets for LVS, with the average analyst target price suggesting a slight downside from the current stock price, though the GF Value estimates an upside.

**4. Sands China (NYSE: LVS) marks 10th SME milestone with MOP 119.4B, 83% local buys**
- Source: Stock Titan | 20251209T131642 | Bullish | Relevance: 99%
- Sands China celebrated the 10th anniversary of its Local Small, Medium and Micro Suppliers Support Programme with a ceremony, releasing a commemorative booklet, and hosting the 2025 Sands Supplier Excellence Awards. Since its 2015 launch, the program has generated MOP 119.4 billion in procurement, with 83% sourced locally, engaging 4,700 SMEs. The event recognized 40 long-term partners and awarded seven outstanding suppliers, emphasizing Sands China's commitment to Macao's economic diversification and local business development.

**5. Sands China Celebrates 10th Anniversary of Local SME Supplier Support Programme and Hosts Supplier Excellence Awards**
- Source: PR Newswire | 20251209T130819 | Bullish | Relevance: 98%
-  Sands China celebrated the 10th anniversary of its Local Small, Medium and Micro Suppliers Support Programme with an event at The Londoner Macao, including the launch of a commemorative booklet. The celebration also featured the 2025 Sands Supplier Excellence Awards and a networking session for local businesses. This initiative, co-launched with the Macao Chamber of Commerce in 2015, aims to support local SMEs and has generated MOP 119.4 billion in procurement, with 83% local sourcing.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $68 | $67 | +1% |
| 2025-12-01 | Argus Research | $80 | $65 | +23% |
| 2025-11-18 | Wells Fargo | $66 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-12-01 | Argus Research | main | Buy |
| 2025-11-18 | Wells Fargo | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($13.25M) |
| Sells | 12 ($64.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 6.2% (-2.0%)
- Capital Research Glo: 5.0% (-30.9%)
- Blackrock Inc.: 4.0% (-0.1%)
- Price (T.Rowe) Assoc: 2.2% (-7.8%)
- State Street Corpora: 2.1% (-7.2%)

### Key Risks

1. Heavy insider selling: $65M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Forward P/E 20.9x stretched relative to 10% growth. Quality metrics strong (ROE 66%). Analyst sentiment positive (2 raises, avg +12%). Insider selling cluster ($64.9M in 90 days), potential headwind. Institutional flow bearish (8 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $45.6B |
| Beta | 0.97 |
| 52W Range | $30.18 - $70.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 20.9 |
| Current P/E | 22.9 |
| YoY Growth | 9.6% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at -2.2% (minimal 5-day change). Below STRENGTH zone by 5.2pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.20% (CS: 26) | Weak |
| RSI_14 | 58.3 | Neutral |
| MACD Histogram | -0.49 | Bearish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 1.110x | Above |
| vs SMA200 | 1.356x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $66.47
- **Stop Loss:** $63.11 (5.1% risk)
- **Target:** $69.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 297
- **Position Value:** $19,741.59
- **Portfolio %:** 19.74%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-01-28 (Est: $0.75)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.62 | $0.78 | +25.4% |
| 2025Q2 | $0.53 | $0.79 | +48.9% |
| 2025Q1 | $0.57 | $0.59 | +3.8% |
| 2024Q4 | $0.58 | $0.54 | -6.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*